FindTrial
Sign In

Application of Remimazolam combined with Goal-Directed Fluid Therapy in elderly patients undergoing hip surgery: A randomized controlled trial

Application of Remimazolam combined with Goal-Directed Fluid Therapy in elderly patients undergoing hip surgery: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074707
Enrollment
Unknown
Registered
2023-08-14
Start date
2023-08-15
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip surgery in elderly patients

Interventions

Group R:Intravenous use of Remimazolam
Group P:Intravenous Propofol

Sponsors

Chaohu Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: (i) Elderly patients undergoing elective hip surgery; (ii) Age =65 years, <90 years, BMI 18-28kg/m2 ; (iii) ASA grade I-III; (iv) No unconsciousness and communication; (v) No history of atrial fibrillation.

Exclusion criteria

Exclusion criteria: ? Long-term bedridden patients; ? Severe cardiac, pulmonary, hepatic, and renal insufficiency or dysfunction; ? Coagulation dysfunction; ? History of allergy to anesthetic drugs.

Design outcomes

Primary

MeasureTime frame
Intraoperative fluid use;Vasoactive drug use;Blood Lactate;NRS Pain Score;Postoperative cognitive dysfunction;—

Secondary

MeasureTime frame
Intubated cardiovascular response;Record anesthesia time, surgery time, PACU time, ICU stay, total postoperative stay;postoperative complication;Opioid use;—

Countries

China

Contacts

Public ContactXia Xiaoqiong

Chaohu Hospital of Anhui Medical University

xxq2366833@sina.com+86 139 6638 6669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026